KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Assets Average (2016 - 2025)

Historic Assets Average for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $57.1 billion.

  • Gilead Sciences' Assets Average rose 568.9% to $57.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $57.1 billion, marking a year-over-year increase of 568.9%. This contributed to the annual value of $60.6 billion for FY2024, which is 333.29% down from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Assets Average is $57.1 billion, which was up 568.9% from $56.1 billion recorded in Q2 2025.
  • Gilead Sciences' Assets Average's 5-year high stood at $67.9 billion during Q1 2021, with a 5-year trough of $54.1 billion in Q3 2024.
  • Over the past 5 years, Gilead Sciences' median Assets Average value was $62.4 billion (recorded in 2023), while the average stood at $61.6 billion.
  • As far as peak fluctuations go, Gilead Sciences' Assets Average skyrocketed by 1711.78% in 2021, and later crashed by 1331.57% in 2024.
  • Gilead Sciences' Assets Average (Quarter) stood at $67.5 billion in 2021, then decreased by 6.9% to $62.9 billion in 2022, then fell by 0.98% to $62.2 billion in 2023, then fell by 8.82% to $56.8 billion in 2024, then rose by 0.65% to $57.1 billion in 2025.
  • Its Assets Average stands at $57.1 billion for Q3 2025, versus $56.1 billion for Q2 2025 and $57.7 billion for Q1 2025.